Fulcrum Therapeutics Inc (NASDAQ:FULC)

8.39
Delayed Data
As of May 24
 +0.02 / +0.24%
Today’s Change
6.85
Today|||52-Week Range
33.10
-52.57%
Year-to-Date

Today’s Trading

Previous close8.34
Today’s open8.23
Day’s range7.97 - 8.55
Volume739,624
Average volume (3 months)631,769
Market cap$348.0M
Data as of 4:00pm ET, 05/24/2022

Growth & Valuation

Earnings growth (last year)+18.15%
Earnings growth (this year)-14.11%
Earnings growth (next 5 years)+12.20%
Revenue growth (last year)+117.19%
P/E ratioNM
Price/Sales32.64
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
EYPTEyePoint Pharmaceuti...-0.53-5.50%
ZYMEZymeworks Inc+0.01+0.17%
----
ABUSArbutus Biopharma Co...-0.21-8.75%
Data as of 4:00pm ET, 05/24/2022

Financials

Next reporting dateAugust 29, 2022
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$19.2M
Annual profit (last year)-$80.8M
Net profit margin-421.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts